October 8, 2014

Identification of Recurrent FGFR3–TACC3 Fusion Oncogenes from Lung Adenocarcinoma

Key Points

Key points are not available for this paper at this time.

Abstract

FGFR3-TACC3 rearrangements occur in a subset of patients with lung adenocarcinoma. Such patients should be considered for clinical trials featuring FGFR inhibitors.

Ask AI

Helpful

Bookmark

Ask AI

Helpful

Bookmark

Cite This Study

Capelletti et al. (Wed,) studied this question.

synapsesocial.com/papers/69de988b6bae133e7de9426c https://doi.org/https://doi.org/10.1158/1078-0432.ccr-14-1337

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Sequence Alignment/Map format and SAMtools2009 · 67,750 citations
2TRK-Fused Gene (TFG) Is a New Partner of ALK in Anaplastic Large Cell Lymphoma Producing Two Structurally DifferentTFG-ALK Translocations1999 · 280 citations
3Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing2009 · 1,509 citations
4Frequency and Distinctive Spectrum of <i>KRAS</i> Mutations in Never Smokers with Lung Adenocarcinoma2008 · 571 citations
5KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only2012 · 262 citations